Multifocal intraocular lens exchange to monofocal for the management of neuroadaptation failure.

"availability of data and materials available upon request. declarations ethics approval and consent to participate ethical board committee (comite etico de investigacion medica instituto de microgirurgia ocular ref number: 210321"

"Declarations Ethics approval and consent to participateEthical Board Committee (Comite Etico de Investigacion Medica Instituto de Microgirurgia Ocular Ref number: 210321-167) approval was obtained for the purpose of this investigation. Consent for publicationAll individuals involved in this study gave their consent for the publication of the manuscript. Competing interestsJorge L. Alio: Consultant/Advisor and Clinical Research Grant for Akkolens; Clinical Research Grant and Consultant/Advisor for Carl Zeiss Meditec; Clinical Research Grant for CSO; Consultant/Advisor and Clinical Research Grant for Hanita Lenses; Lecture Fees from Ophthec; Equity Owner for Tekia; Associate editor of Eye and Vision. Colm McAlinden: Dr McAlinden has received consultancy fees / travel support from: Acufocus (Irvine, California, USA), Alcon (Fort Worth, Texas, USA) Allergan (Irvine, California, USA), Bausch and Lomb (Bridgewater, New Jersey, USA), Bayer (Leverkusen, Germany), Carl Zeiss Meditec (Dublin, California, USA), ClarVista (Aliso Viejo, California, USA), Cutting Edge (Labége, France), BVI (Liège, Belgium), Coopervision (Pleasanton, California, USA), CORD LLC (Laguna Beach, California, USA), Cutting Edge (Labége, France), European Society of Cataract and Refractive Surgeons (Dublin, Ireland), Eye and Vision Journal (Wenzhou, China), Eye center Vista Alpina (Switzerland), Fudan University (Fudan, China), Glaukos (San Clemente, California, USA), Hoya (Frankfurt, Germany), LensGen (Irvine, California, USA), Ludwig-Maximilians-University (München, Germany), Novartis (Basel, Switzerland), Ocudyne (Roseville, Minnesota, USA), Ora (Andover, Massachusetts, USA), Perfect Lens (Irvine, California, USA), Pharmerit (Newton, Massachusetts, USA), PhysIOL (Liège, Belgium), RxSight (Aliso Viejo, California, USA), Santen (Osaka, Japan), Schwind (Kleinostheim, Germany), SightGlass vision (Menlo Park, California, USA), Science in Vision (Bend, Oregan, USA), STAAR Surgical (Monrovia, California, USA), targomed GmbH (Bruchsal, Germany), Thea pharmaceuticals (Clemont-Ferrand, France), University of Houston (Houston, Texas, USA), University of Michigan (Ann Arbor, Michigan, USA), University of São Paulo (São Paulo, Brazil), Wenzhou Medical University (Wenzhou, China), and Yoshida Eye Institute (Chiba, Japan). Jorge L. Alió del Barrio: Consultant for CSO (Florence, Italy). Olena Al-Shymali: None. Mario Canto: None. Laura Primavera: None. Competing interests Jorge L. Alio: Consultant/Advisor and Clinical Research Grant for Akkolens; Clinical Research Grant and Consultant/Advisor for Carl Zeiss Meditec; Clinical Research Grant for CSO; Consultant/Advisor and Clinical Research Grant for Hanita Lenses; Lecture Fees from Ophthec; Equity Owner for Tekia; Associate editor of Eye and Vision. Colm McAlinden: Dr McAlinden has received consultancy fees / travel support from: Acufocus (Irvine, California, USA), Alcon (Fort Worth, Texas, USA) Allergan (Irvine, California, USA), Bausch and Lomb (Bridgewater, New Jersey, USA), Bayer (Leverkusen, Germany), Carl Zeiss Meditec (Dublin, California, USA), ClarVista (Aliso Viejo, California, USA), Cutting Edge (Labége, France), BVI (Liège, Belgium), Coopervision (Pleasanton, California, USA), CORD LLC (Laguna Beach, California, USA), Cutting Edge (Labége, France), European Society of Cataract and Refractive Surgeons (Dublin, Ireland), Eye and Vision Journal (Wenzhou, China), Eye center Vista Alpina (Switzerland), Fudan University (Fudan, China), Glaukos (San Clemente, California, USA), Hoya (Frankfurt, Germany), LensGen (Irvine, California, USA), Ludwig-Maximilians-University (München, Germany), Novartis (Basel, Switzerland), Ocudyne (Roseville, Minnesota, USA), Ora (Andover, Massachusetts, USA), Perfect Lens (Irvine, California, USA), Pharmerit (Newton, Massachusetts, USA), PhysIOL (Liège, Belgium), RxSight (Aliso Viejo, California, USA), Santen (Osaka, Japan), Schwind (Kleinostheim, Germany), SightGlass vision (Menlo Park, California, USA), Science in Vision (Bend, Oregan, USA), STAAR Surgical (Monrovia, California, USA), targomed GmbH (Bruchsal, Germany), Thea pharmaceuticals (Clemont-Ferrand, France), University of Houston (Houston, Texas, USA), University of Michigan (Ann Arbor, Michigan, USA), University of São Paulo (São Paulo, Brazil), Wenzhou Medical University (Wenzhou, China), and Yoshida Eye Institute (Chiba, Japan). Jorge L. Alió del Barrio: Consultant for CSO (Florence, Italy). Olena Al-Shymali: None. Mario Canto: None. Laura Primavera: None."

"Funding This study was supported in part by the Network for Cooperative Research in Health “OFTARED”, Nodo Dioptrio Ocular, Biobanco Iberia (Reference: RD16/0008/0012), funded by Instituto de Salud Carlos III and co-funded by European Regional Development Fund (ERDF), Project “A way to make Europe”."